Education
About Us
Working with TipRanks
Follow Us
Certara (CERT)
NASDAQ:CERT
CERT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$8.64 - $15.69
Previous CloseN/A
Volume176.64K
Average Volume (3M)1.44M
Market Cap
$1.75B
Enterprise Value$2.03B
Total Cash (Recent Filing)$162.27M
Total Debt (Recent Filing)$307.86M
Price to Earnings (P/E)220.0
Beta1.35
Next Earnings
Nov 05, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding160,623,580
10 Day Avg. Volume1,114,163
30 Day Avg. Volume1,437,806
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.16
Enterprise Value/Revenue5.00
Enterprise Value/Gross Profit8.67
Enterprise Value/Ebitda41.00
Forecast
1Y Price Target
$14.50Price Target Upside32.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThere was strong 15% services bookings growth supported by uptake across all customer sizes.
Growth PotentialIncreased adoption bolstered by new launches/version updates for high-value offerings could drive meaningful upside to CERT's valuation while offsetting any exposure to sector-wide spending uncertainties.
Regulatory ApprovalCertara's PBPK modeling platform became the first and only software to receive European Medicines Agency qualification.
Bears Say
End Market WeaknessEnd market weakness was evident in tier 2 software bookings and tier 1 services bookings performance in the quarter.
Market Demand ChallengesDemand trends for the company’s core biosimulation business remain challenged.
Certara News
CERT FAQ
What was Certara’s price range in the past 12 months?
Certara lowest stock price was $8.63 and its highest was $15.69 in the past 12 months.
What is Certara’s market cap?
Certara’s market cap is $1.75B.
When is Certara’s upcoming earnings report date?
Certara’s upcoming earnings report date is Nov 05, 2025 which is in 68 days.
How were Certara’s earnings last quarter?
Certara released its earnings results on Aug 06, 2025. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.1 by -$0.03.
Is Certara overvalued?
According to Wall Street analysts Certara’s price is currently Undervalued.
Does Certara pay dividends?
Certara does not currently pay dividends.
What is Certara’s EPS estimate?
Certara’s EPS estimate is 0.11.
How many shares outstanding does Certara have?
Certara has 160,623,580 shares outstanding.
What happened to Certara’s price movement after its last earnings report?
Certara reported an EPS of $0.07 in its last earnings report, missing expectations of $0.1. Following the earnings report the stock price went up 18.153%.
Which hedge fund is a major shareholder of Certara?
Currently, no hedge funds are holding shares in CERT
Certara Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.50 (32.18% Upside)
$14.50 (32.18% Upside)
Blogger Sentiment
Bullish
CERT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 6.7%
Last 30 Days ▲ 2.1%
Last 30 Days ▲ 2.1%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.64%
12-Months-Change
Fundamentals
Return on Equity
0.76%
Trailing 12-Months
Asset Growth
0.25%
Trailing 12-Months
Company Description
Certara
Certara (CERT) is a leading provider of biosimulation software and technology-enabled services that accelerate drug discovery and development. Operating within the healthcare and life sciences sectors, Certara offers a comprehensive suite of solutions designed to optimize and streamline the drug development process. The company's core products and services include modeling and simulation software, regulatory science consulting, and clinical pharmacology services, which help pharmaceutical companies and regulatory agencies make data-driven decisions.
CERT Company Deck
CERT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in terms of revenue and bookings growth, driven by software, especially Simcyp, and significant regulatory achievements. However, there were concerns about timing issues with Tier 1 software renewals and macroeconomic challenges impacting customer decision-making. Despite these issues, the company's strong execution and positive outlook contributed to an overall positive sentiment.View all CERT earnings summariesCERT Stock 12 Month Forecast
Average Price Target
$14.50
▲(32.18% Upside)
Technical Analysis
Ownership Overview
2.30% Insiders
25.59% Mutual Funds
28.45% Other Institutional Investors
27.20% Public Companies and
Individual Investors